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Abstract
Background Community pharmacists require access to consumers’
information about their medicines and health-related conditions to
make informed decisions regarding treatment options. Open com-
munication between consumers and pharmacists is ideal although
consumers are only likely to disclose relevant information if they feel
that their privacy requirements are being acknowledged and adhered
to.
Objective This study sets out to explore community pharmacy pri-
vacy practices, experiences and expectations and the utilization of
available space to achieve privacy.
Methods Qualitative methods were used, comprising a series of
face-to-face interviews with 25 pharmacists and 55 pharmacy cus-
tomers in Perth, Western Australia, between June and August 2013.
Results The use of private consultation areas for certain services
and sensitive discussions was supported by pharmacists and con-
sumers although there was recognition that workflow processes in
some pharmacies may need to change to maximize the use of private
areas. Pharmacy staff adopted various strategies to overcome pri-
vacy obstacles such as taking consumers to a quieter part of the
pharmacy, avoiding exposure of sensitive items through packaging,
lowering of voices, interacting during pharmacy quiet times and tele-
phoning consumers. Pharmacy staff and consumers regularly had to
apply judgement to achieve the required level of privacy.
Discussion Management of privacy can be challenging in the com-
munity pharmacy environment, and on-going work in this area is
important. As community pharmacy practice is increasingly becom-
ing more involved in advanced medication and disease state
management services with unique privacy requirements, pharmacies’
layouts and systems to address privacy challenges require a proactive
approach.
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Introduction
Australia has approximately 5450 community
pharmacies that provide a range of medication-
related services such as dispensing of prescrip-
tions, counselling about appropriate use of
medicines, provision of healthcare information
and supply of non-prescription medicines.1
The Commonwealth Government restricts the
location of community pharmacies through
Pharmacy Location Rules to facilitate equitable
access to medication services regardless of con-
sumers’ location.2 Furthermore, requirements
regarding pharmacy premises are specified under
state and territory legislation.3 In most jurisdic-
tions, pharmacies require an area for private
consultation. For example, in Western Aus-
tralia, Section 7 of the Pharmacy Regulations
2010 (WA) specifies as follows:
The premises are to have an area in which a con-
sultation conducted by a pharmacist is not
reasonably likely to be overheard by a person not
a party to the consultation.
The need to regulate community pharmacy
‘space’ to ensure privacy is justified by pharma-
cists’ use of information about consumers’
medicines and health conditions to make
informed decisions regarding treatment options.
Open communication between consumers and
pharmacists is ideal, although consumers and
carers are only likely to disclose relevant infor-
mation if they feel that their privacy require-
ments are being acknowledged and adhered to.4
Strict adherence to Australian community phar-
macy privacy requirements is somewhat
complicated by the retail element as pharmacists
and pharmacy staff provide services mostly in
the public eye.
Changes in the healthcare landscape over
recent years have resulted in the expansion of
the role of community pharmacists. Certain new
services have premises requirements, for exam-
ple government-funded in-pharmacy medication
review services introduced in 2012 require a
screened area or separate room that is distinct
from the general public area of a pharmacy.5
Recent changes to legislation that enable
pharmacist-administered influenza vaccination
services in Western Australia similarly require
pharmacies to have a screened area or private
room with sufficient space to adminis-
ter vaccinations.6
In addition to the physical pharmacy space
requirements, pharmacy staff must comply with
privacy processes and procedures as specified in
the Privacy Act 1988 (Cth). The Act defines per-
sonal information as information or an opinion
about an individual who is identified or is ‘rea-
sonably identifiable’, and includes a person’s
name, address, Medicare number or any other
health information such as notes or opinions.7
Pharmacists must also comply with the Code of
Conduct for Registered Health Practitioners,
which states health professionals must ‘protect
the privacy and right to confidentiality of
patients and clients’.8 The Pharmaceutical Soci-
ety of Australia’s Code of Ethics and
Professional Practice Standards also require
safeguarding the consumer’s right to privacy
and confidentiality at all times.9,10
Pharmacy privacy research
A 2004 systematic review of community phar-
macy services highlighted consumers’ concerns
about the level of privacy and that utilization of
community pharmacies might depend on a phar-
macy’s facilities for a private discussion.11 The
concept of privacy in pharmacies has been the
subject of a number of studies, mostly in the con-
text of a particular product, service or medical
condition. A recent Australian study involving 74
mental health consumers and carers found con-
sumers are likely to form trusting relationships
with community pharmacy staff if they perceive
pharmacies as safe health spaces.12 The research
identified a need for pharmacy staff to be more
discreet when calling out patient names, having
private conversations in the pharmacy and expos-
ing medication packs being purchased or
issued.13 Participants of a 2010 United Kingdom
(UK) community pharmacy-based cardiovascular
screening study similarly identified concerns
about confidentiality and lack of privacy as barri-
ers to participating in screening services.14 A 2001
pharmacy-led intervention in The Netherlands
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focused on pharmacies as sources of informa-
tion, reporting lack of pharmacy privacy led to
reluctance to ask questions.15
A recent Australian study involving consumer
focus groups identified a lack of privacy as a
major logistical barrier to consumers’ participa-
tion in chronic disease management pro-
grammes.16 Similarly, in the UK, research to
enhance the utilization of community pharmacy
services identified lack of privacy and confiden-
tiality as crucial obstacles that could inhibit
service utilization.17
A number of studies have focused on phar-
macy privacy and the provision of emergency
hormonal contraceptives (the ‘morning-after
pill’). A ‘mystery shopper’ Australian study
reported low use of private and semi-private
consultation areas.18 Other emergency hormonal
contraceptive studies similarly highlighted con-
cerns around lack of pharmacy privacy.19–23
These studies indicate that, from the con-
sumer perspective, there is a need for increased
sensitivity about privacy requirements in com-
munity pharmacy practice. Although some of
the newer professional services require the use
of separate consultation areas, it is unknown
whether these areas are being used as intended.
UK research found consultation rooms were
perceived as less accessible than originally envi-
sioned and were being used for other purposes
or were not patient-friendly, making their
utilization challenging.24
Although there are regulatory requirements
about layout and procedures to protect con-
sumers’ privacy in pharmacies, the literature
suggests compliance with privacy in pharmacy
practice is challenging.12–15 A need was therefore
identified to explore community pharmacy pri-
vacy practices, experiences and expectations
from the perspectives of both pharmacists and
pharmacy consumers.
Methods
This study utilized qualitative methods com-
prising a series of interviews with pharmacists
and pharmacy customers in Perth, Western
Australia, to explore privacy practices, experi-
ences and expectations and the utilization of
available space to achieve privacy. Qualitative
methodology allowed exploration of partici-
pants’ views. Low-risk ethical approval was
granted (PH-17-13).
Participant recruitment
The selection of pharmacies followed a purpo-
sive sampling approach to cover a range of
characteristics and population demographics. In
2013, there were 584 pharmacies in Western
Australia (WA), 424 of which were in the capital
city, Perth.25 Perth metropolitan pharmacies
were categorized geographically as north-west,
south-west, north-east, south-east and central. A
further categorization process followed whereby
pharmacies were allocated according to socio-
economic area (based on median house price
for the suburb), size of pharmacy (based on
average prescription number and number of
staff), location (major/smaller shopping centre
or street front) and whether pharmacies were
independently owned or member of a brand or
banner group. Pharmacies from each category
were selected and a shortlist of 66 pharmacies
created. Pharmacies were limited to approxi-
mately 25 km from the city centre for
logistical reasons.
Pharmacist managers were initially
approached by telephone and if interested to
participate were emailed copies of the partici-
pant information sheet and consent form. Face-
to-face interviews were conducted during
business hours at the pharmacies at times conve-
nient to the pharmacists, and participants
received a $50 gift card in recognition of
their involvement.
After each pharmacist’s interview, the phar-
macist and researcher approached pharmacy
consumers to be interviewed. If the consumers
agreed to the interview, they were provided with
an information sheet and interviewed by the
researcher (CG) during the same visit. Interviews
took place face-to-face in the pharmacy in an
area comfortable to the consumer, either in a
quiet area, a semi-private area or a consulting
room if available. All participants signed a
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consent form before being interviewed. Con-
sumer data were not shared with pharmacy staff.
The recruitment of pharmacist and consumer
participants ceased when data saturation was
perceived by the research team; qualitative
methods suggest this is achieved with samples of
20–25 participants.26
Interview guides
A semi-structured guide with 12 open-ended
questions with prompts for elaboration was used
for the pharmacist interviews. While qualitative
methods generally advocate unstructured inter-
views, semi-structured (guided) discussions that
allow participants to follow particular lines of
reflection, yet within a framework controlled by
the interviewer, are commonly applied.27 Discus-
sion points were developed with reference to the
literature and explored:
1. Pharmacists’ perspectives of the use of vari-
ous consultation areas in the pharmacy
including the use of space for the provision of
newer pharmacy services
2. Advantages and disadvantages of using these
spaces
3. Pharmacists’ perceptions of consumers’ needs
and expectations relating to privacy and con-
fidentiality
4. Examples of situations during which phar-
macy staff were unsure about their privacy
and confidentiality obligations.
The consumer interview guide consisted of
nine open-ended questions that followed a struc-
tured format. Questions to consumers explored
are as follows:
1. Consumers’ perceptions of privacy during
consultations in pharmacies
2. Satisfaction with privacy and confidentiality
in interactions with pharmacy staff
3. Consumers’ knowledge of privacy in relation
to pharmacy.
Interview guides were validated by all four team
members as well as two academic colleagues, seek-
ing feedback on questions, format and suggestions
for improvement. Minor changes regarding the
flow of questions were incorporated, and the
guides were reviewed for construct validity27 by a
pharmacist and consumer.
Data management and analysis
Pharmacist interviews were audio-recorded, sup-
plemented with notes and diagrams, then de-
identified and transcribed verbatim. Information
from consumer interviews was noted on inter-
view guides during the interviews. The inter-
views were conducted with the participants’
consent but not recorded to minimize discom-
fort of the consumers when unprepared for
the interview.28,29
NVivo (Version 9.0) (NVivo qualitative data
analysis software; QSR International Pty Ltd.
Version 9, Doncaster, Victoria, Australia) was
used to organize the data. Thematic analysis of
the data was informed by the general inductive
approach30 and comprised multiple stages. The
data were coded, and emergent themes were
noted with supporting quotations within each
theme. The themes were organized under distinc-
tive headings addressing the research objectives.
To ensure reliability of the analysis, all authors
reviewed and agreed upon the themes. This
involved members of the research team read-
ing and re-reading the transcripts to gain an
understanding of the broad issues. Specific
descriptive topics and themes were developed to
capture core messages reported by participants.
Results
Participants
Interviews were conducted between June and
August 2013. Twenty-five pharmacists (13
males, 12 females) from 25 community pharma-
cies participated: 12 were pharmacy managers,
10 were owners and three the pharmacist-
in-charge. Fourteen had <10 years’ experience,
eight had 10–20 years’ experience, and three had
more than 20 years’ experience. Thirteen of the
participating pharmacies were independently
owned; the remaining 12 were members of ban-
ner groups. The majority of the pharmacies
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(n = 15) were located as street-front pharmacies,
with seven in shopping centres and three next to
a medical centre. The duration of the pharmacist
interviews averaged 30 min (17.0–58.5 min).
The 55 consumer participants (on average two
from each pharmacy) centred around 55 years
of age and comprised 34 females and 21 males.
The majority of the participants were regular
clients at the pharmacy where they were inter-
viewed. Although most of the consumers visited
the pharmacies to obtain prescription medicines
20 of the consumers presented for another rea-
son, that is to purchase a non-prescription
product or ask for advice.
Themes common to pharmacists and consumers
A number of themes were common to the phar-
macists’ and consumers’ responses:
1. Support for the use of allocated private con-
sultation areas
2. Challenges with overhearing conversations
3. Visibility of people and products
4. Judgement regarding required privacy.
These themes are presented with illustrative
quotations: pharmacists’ responses are repre-
sented with ‘P’ and consumers’ with ‘C’.
Support for the use of allocated private
consultation areas
The majority of the pharmacies had allocated
spaces for private discussions, ranging from a
seated semi-private consultation area (in a quiet
corner of the pharmacy) to a semi-private booth
(partitioned area at counter) or a separate
consultation room (Table 1). Three of the phar-
macies had more than one area whereas four of
the pharmacies had no specific allocated space
for private discussions.
Pharmacists’ comments
Pharmacist participants reported that the pri-
vate consultation rooms were used to provide in-
pharmacy medication review services. Private
consultation rooms were also increasingly used
for discussions sensitive in nature such as the
supply of medicines for treatment of vaginal
candidiasis and genital herpes, and requests for
emergency hormonal contraceptives. Overall,
there was agreement between the pharmacists
that dedicated space for private or semi-private
discussions was a necessity for the pharmacy
profession to progress and embrace expanding
roles. Although most pharmacists were positive
about private rooms, there were some reserva-
tions based on cost (sacrificing high-rent-value
retail space) and perceived uneasiness of con-
sumers in being taken into a room (Table 2).
One pharmacist proposed a solution to over-
coming the barrier of having the pharmacist
segregated in a consultation room and unable to
supervise other activities:
. . .I have thought that maybe having these [Per-
spex barriers] up a little bit higher would be good,
because people can walk past and see what’s hap-
pening. But I need to be in here and be able to see
out there [into the pharmacy]. It’s not the most pri-
vate, but it’s used a lot – I feel it gets good use. It’s
practical. . .P24
The management of consumers who received
medicines through staged-supply services (daily
or weekly supply) or who were using opioid sub-
stitution therapies varied between pharmacies;
these consumers were served at the main or
dispensary counters, or in a dedicated semi-
private area.
Consumers’ comments
A number of consumers were aware of a private
consultation room within the pharmacy as a
recent and positive addition:
. . .When I saw they built this room, I thought it
was a good idea, because sometimes people want
to be private. . .C24




Seated consultation area in pharmacy 6
Consultation room as well as seated consultation area 3
Booth 2
No dedicated private area 4
†n = 25 pharmacies.
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The availability of a private room encouraged
some consumers to have more discussions in
the pharmacy:
. . .I wouldn’t discuss things out there that I
would be bothered with . . . [but would rather
use a private room], not necessarily for confiden-
tial things, you just want them to be
private. . .C19
Consumers who used pharmacies without a
private consultation area highlighted a need for
such an area within the pharmacy for interac-
tions that may require privacy:
. . .The only thing I would say is that if it was
something of a more serious nature or more
personal nature, maybe there’s an area of
the pharmacy that could be looked at for
speaking to somebody who’s particularly sensi-
tive or has a serious health issue that they
don’t want everybody else to know or over-
hear. . .C10
Challenges with overhearing conversations
Both pharmacists and consumers highlighted
pharmacy layout shortcomings that pose diffi-
culties with keeping conversations private.
Pharmacists’ comments
Table 3 is a summary of situations described by
pharmacists when consumers who were present
in the pharmacy could overhear conversations.
The majority of pharmacists indicated that
counselling was provided at the counter unless
a need for greater privacy was identified.
However, pharmacy counters were identified
as a specific problematic area to be man-
aged to prevent consumers overhearing pri-
vate conversations:
. . .people queuing to pay at the counter and you’ve
got counselling happening at the same time. It’s





. . .It’s [consultations] got to be done in private, that’s sort of the changes that I think I’m
going to need to move forward. You’re going to be a pharmacist sitting out here, having
consultations. . .. . .So, refit. . .P07
. . .Well, it’s good that we’re doing that; it’s becoming more of a pharmacist’s role in society,
but you definitely need a private area, consultation area . . .. . . somewhere where you can sit
and discuss. That was the purpose for having this room . . ...Vaccinations . . .. . .. I think that
is something that we’d be able to do in the pharmacy, we’d be able to roll it out here because




. . .So, we believe that the consulting room will actually make a huge difference in the way of
how comfortable we are . . . and we are actually thinking that we can do some weight
management, where we can check the patient’s weight and waist measurement. . .P14
Better-informed
about consumers
. . .Recently, with talking with mental health customers, I’m now more aware and . . .. now
sitting down and talking to people with mental health, it just makes me understand more. I
was not really judging them before, but all the things now fall in place when you sit down and
talk to them about other things . . . and it makes us a better-informed health professional and




. . .It’s not a physical area that’s the biggest barrier, it’s the workload put on the
pharmacists . . . there has to be enough money in the pharmacy to allow for two pharmacists,
essentially. I think that’s the only way. . .P16
Financial barriers . . .but then you come back to the cost basis – how do you do this? What do you do? How
many people can you afford to employ? Who’s going to pay for it? You’re paying for a shop
per square metre, it’s the same everywhere in commercial realty. . .P21
Consumers feeling
uncomfortable
. . .I think the odd person thinks ‘oh, why do I have to go in there’ They might feel a bit
uncomfortable about it, thinking that we might maybe drawing more attention to
them. . .P11
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quite difficult in that way; you just have to try to
be discreet. . .P19
One pharmacist commented on asking con-
sumers to visit the pharmacy during quiet times
to discuss specific issues:
. . . I’ll call them to come to the quieter area at a
quieter time, like early in the morning or after
5.30 pm – it’s a very quiet pharmacy at that time.
So that’s what I do if they really want to discuss
the medication or a serious issue. Because all the
customers here, we’ve known about 10–15 years,
so they listen and come after 5.30. . .P20
Another challenging situation was to verify
the identity of a person requesting information
over the telephone:
. . .How do we know that that’s the person they say
they are? What kind of information do you get
from them? P03
Consumers’ comments
Most consumers indicated they felt comfort-
able within the pharmacy environment and
that their privacy was protected during inter-
actions with the staff. A number perceived
this was due to the absence or scarcity of
other consumers in the pharmacy at the time
they received counselling. However, should the
pharmacy have been busy at the time, some
reported they would choose a less busy time
to ask questions:
. . .There was no-one else around. I think if I was
not comfortable, I would have left, the pharmacist
knows that. . .C04
Consumers highlighted staff strategies to
enhance protection of their privacy during inter-
actions to make them feel comfortable. These
actions included lowering their tone of voice and
moving aside to a private area to provide
more privacy:
. . .The centre of the counter seems very full-on,
and there is a lot of activity happening, so whoever
we were talking to would always, very discreetly,
not imposingly, but very discreetly pull us aside to
talk about things. . .C01
There were comments from some consumers
about having overheard private conversations at
the front counter:
. . .I must admit, I’ve heard some interesting things
along the way. . .C32
. . .I was in a pharmacy in [suburb] once . . .
buying something at the counter, and the phar-
macy assistant called out across the shop,
which was bigger than this one, ‘Oh, Mr so
and so, your methadone’s here!’ . . . that was a
bad one. . .C43
Table 3 Challenging situations for overhearing conversations identified by pharmacists
Small pharmacies . . .this particular pharmacy is small, so it’s easy for a customer to overhear a conversation
from another customer. . .P10
Consumers with
hearing problems
. . .We had a lady and she couldn’t understand. . .and I was trying to explain to her. . .and
there was a customer waiting behind, and while I was trying to be really quiet, there was only
so much [I could lower my voice] or the [lady] couldn’t hear . . . but, as much as you try to
keep that private, you can’t . . . you’re trying to explain to someone and another person is
standing really close and the lady’s talking loudly, so, I guess in that way, as much as you try




. . .My friend, she had a urinary tract infection . . . and this was at the cashier, in front of
everyone, and the [pharmacy assistant] said ‘Can I ask you a personal question – do you go
to the toilet after you have sex?’ and my friend . . . and her husband was, like, ‘I’m out of
here.’ And she said she was so embarrassed. . .P03
Telephone
conversations
. . .if you’re on the phone with someone who is hearing impaired and they say ‘speak up,
speak up’ then you just don’t know who might be listening, and you have to speak up because
they can’t hear you – and you may get a customer saying ‘well, what was that all about?’P23
. . .Because of the high volume of methadone clients, we’re constantly communicating [by
telephone] with doctors and nurses, prison officers, police . . . regarding this specific group of
people who need a lot of attention. . . so phone is difficult. . .P08
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Visibility of people and products
Table 4 provides a summary of challenges to
overcome information that could be visible to
pharmacy customers and some solutions identi-
fied by pharmacists. Another issue identified
was pharmacy customers recognizing each other.
One consumer referred to the challenges of liv-
ing in smaller towns with only one pharmacy,
where pharmacy customers tend to know
each other:
. . .I have not felt comfortable . . . sometimes you
are asked questions that you’d rather not every-
body knows. . . it’s just not comfortable
especially if you live in a small town. Even if
you’re buying Panadol, you don’t want your
neighbour to know – it’s none of their business.
I don’t think they [the staff] consciously talk
too loud; it’s just if there’s too many cus-
tomers. . .C04
Judgement regarding required privacy
Both pharmacists and consumers recognized the
need for sensitivity and professional judgement
to facilitate the required level of privacy.
Pharmacists’ comments
An increased need for privacy appeared to
depend on the nature of the medication being
supplied and the pharmacist detecting con-
sumers’ cues. Specific medicines identified that
should be managed with extra privacy were the
emergency hormonal contraceptive, medicines
for erectile dysfunction, medicines for genital
herpes simplex infections and dexamphetamine.
Pharmacists generally offered the level of pri-
vacy to a consumer that they judged desirable by
that consumer, and if this was perceived to be
insufficient, responded further:
. . .You can kind of judge by someone’s . . . body
language, whether or not they’re comfortable,
and, if they’re not, you can always take them
aside. . .P03
. . .you get a feeling for if the patient needs [more
privacy], or isn’t comfortable talking about the
condition or the medication in front of other peo-
ple that are standing there, then they’re always
moved to a separate place or a quiet place and
then we go through it. . .P06
Consumer variability was highlighted, and
pharmacists should use judgement to determine
Table 4 Challenges and solutions to manage visible information identified by pharmacists
Challenges with the space surrounding pharmacy
counters, such as consumers being able to observe
prescriptions or other products being sold
. . .Sometimes . . . I’m talking about blood pressure
medication, other people are standing and have a look on
the box, so you can’t 100% keep it 100% private because
you’re going to take it out and on the box they can see ate
nolol is for the blood pressure, so they know this customer
has blood pressure. . .P20
Measures to prevent consumers from seeing other
consumers’ dispensed products included asking
consumers to sign beforehand and putting the
medicines in a bag before handing it to the
consumer
. . .Scripts are treated carefully; like sometimes we try to get
the patient to sign it, if they’ve signed it beforehand, to
make sure they’re filed away before they’re brought out to
avoid that. Sort of more discrete medications like DDs
[dangerous drugs], dexamphetamines, for example or
Viagra [used for erectile dysfunction], things like that, we
put in a bag before it’s handed out and then we do have this
counselling area for privacy and we’ve also got the partition
section at the end of the counter for privacy as well. . .P11
Visibility of computer screens was mentioned as an
aspect that requires staff awareness, with some of
the pharmacists commenting on the use of ‘wait
screen’ functions or screen savers in-between tasks.
One pharmacist highlighted the situation when
consumers come within close proximity of private
information displayed on computer screens
. . .people walk right to here (entrance to dispensary/
consulting room) and I’m like ‘I’m really sorry, but can you
just step back’ because people don’t realise that they can
see, you know, they can look at the computer screen. . .P03
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the need for increased privacy in particu-
lar circumstances:
. . .I guess it depends on the patient, too. Like, cer-
tain things could be private for one person and
fine for another. . .P10
A need for privacy was noted when consumers
need to remove clothing:
. . .if they have to show me something on their
body, for example, something discreet, might need
to remove clothing . . . we’d come into this closed
room. . .P11
Assumptions were also made based on con-
sumer age, experience and preferences:
. . .Our demographic is mostly elderly people, so
we find in terms of privacy, they don’t really mind.
So they’re not too fussed who we tell, or if we ring
up the doctor; they’re happy for us to do it . . . A
lot of your younger people who are on antidepres-
sants . . . tend to get a little bit more concerned if
you ring up the doctors and things like that, but
most of the elderly patients . . . rather you tell the
doctor what they’re all on and make sure they’re
ok than the younger people that we have. . .P10
. . .Privacy is different for everyone; someone says
‘my diabetes or my heart problem is not private –
you can tell them, you can discuss it,’ but others
say ‘why did you tell someone I had a blood pres-
sure problem?’ You know, privacy is different to
different people. . .P20
One pharmacist commented on strategies used
to avoid opioid substitution therapy consumers
encountering each other at the pharmacy:
. . .When the patient walks in, they’ve actually got
a separate counter . . .. but there is . . . no room, so
people can actually, on the other side, can still see
what they are doing. So, the best thing is . . . for the
pharmacist to look around, if it is someone that
they know, we normally ask them first ‘Do you
want me to do it now?’ and if then it’s up to them
whether they say ‘yay’ or ‘nay’. But it’s normally
only for the other [patient], because you know if
they know each other, like they greet each other . . .
and I normally tell the intern ‘just hold off until the
other person that they know goes’. . .P15
A number of pharmacists identified the man-
agement of unique privacy requirements of
mental health consumers:
. . .We have a lot of mental health patients here. . ..
they do need that one-on-one interaction more
often than not. . .P25
Consumers’ comments
In general, there was implied trust in pharmacists
that consumers’ privacy would be protected. This
was apparently based on staff professionalism,
personal attributes and the personal experience
of the consumer with the pharmacy:
. . .you trust them, that [pharmacy staff] don’t go
discussing you to other people. They’re profession-
als, they shouldn’t be doing that, and I don’t think
they would do that. . .C24
. . .I trust [the pharmacist], especially the way he
is not to reveal anything because that’s the sort
of person he is. I don’t think he’d reveal any-
thing. I have confidence in him, he’s been very
good. . .C39
One consumer specifically identified that pri-
vacy is particularly important for consumers
with sensitive health issues, such as mental
health issues:
. . .I’ve got a bit of a problem with depression . . ..
so that’s why I come here. I feel quite at home
here. . .C54
Others indicated that if they felt uncomfort-
able, they would be proactive in asking for more
privacy or would telephone the pharmacy. How-
ever, some consumers indicated they would not
discuss personal issues to avoid being uncom-
fortable in the pharmacy environment and
rather use the internet to obtain more informa-
tion. One male participant (C36) moved away
from the counter when staff had ‘women’s talk’
with his wife.
Although some consumers had not given
much thought to the subject matter, they felt
assured staff would act appropriately:
. . .I guess it depends on what it’s about. I remem-
ber speaking about my cholesterol tablets and I
certainly didn’t really mind about that, things like
that. I guess if it’s something more private, I’d
probably prefer not to, but probably they
wouldn’t be asking in a big voice at the counter if
it was something more private. . .C26
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Discussion
This study combined the experiences and expec-
tations of pharmacists and consumers regarding
community pharmacy privacy practices; no
other research to date has included this compar-
ison of perspectives. Interviews with both parties
provided valuable insights into facilitators and
barriers in community pharmacy in achieving
privacy. The use of private or semi-private con-
sultation areas for certain services and sensitive
discussions was supported, although workforce
issues should be considered for this model to be
successful. Pharmacy staff adopted various prac-
tices to overcome privacy obstacles such as
taking consumers to a quieter part of the phar-
macy, lowering of voices or avoiding exposure
of sensitive items through the use of packaging.
These strategies demonstrate staff awareness of
the need for privacy and the use of good commu-
nication and practice skills to enhance privacy.
Pharmacists emphasized that professional judge-
ment plays an important role in managing
privacy in everyday practice considering the
retail environment.
The consumers were, generally, comfortable
with the level of privacy experienced in phar-
macy practice, and there was implied trust in
pharmacy staff to protect their privacy. How-
ever, examples were provided of privacy and
confidentiality breaches that related to calling
out consumers’ names to collect their medicines
and mentioning the name of the medicine, over-
hearing conversations or visibility of products at
the counter.
Strategies to optimize pharmacy space to
achieve privacy
Consumers generally received advice at the phar-
macy counter. Some had experienced being
moved aside to a quieter area, and this appeared
universally to be initiated by the pharmacy staff
member. The use of partitioned counselling
booths or consultation rooms, although well
accepted as a concept in pharmacies, was rela-
tively new to consumers and highlighted the
need for staff to further develop communication
skills and workflow strategies. The existence of a
separate consultation room in pharmacies
appeared dependent on available floor space and
recency of fit-outs. Although the use of private
consultation areas was positively perceived by
most pharmacists, there were some reservations
mainly related to the time a seated consultation
would take and the cost for a second on-duty
pharmacist to continue with dispensing or
other patient-centred activities.5,6 Of interest
was that four of the pharmacies did not have
private consultation areas as they did not pro-
vide in-pharmacy medication review services.
The possible reticence of a consumer to be
singled out for consultation in a counselling
booth was also raised, similar to mental health
consumer research.13
Despite the prevalent use of the pharmacy
counter for counselling, consumers appeared
generally satisfied with this level of privacy and
appeared comfortable, either considering their
issue as not highly sensitive or refraining from
discussing highly sensitive issues in the phar-
macy. The level of comfort could also be a result
of the clients being ‘regulars’ at those pharma-
cies, having rapport with the staff could improve
their comfort and confidence with management
of private issues. However, it is concerning to
note that some consumers preferred not to dis-
cuss sensitive issues with a pharmacist due to
perceived lack of privacy, and for these con-
sumers, community pharmacies may not yet be
perceived as a safe health space. This finding is
similar to a study of public attitudes towards
community pharmacies in Qatar, in which half
of the participants stated that a lack of privacy
was the most common barrier to asking pharma-
cists questions.31
Pharmacists highlighted the importance of pri-
vacy when dealing with special patient groups,
and if computer screens are readable from where
consumers stand. Pharmacy staff used various
strategies to make visible information less obvi-
ous, such as asking consumers to sign for
prescription medicine receipt in a more private
area, or placing the medicines in bags before issue.
One unanticipated finding was the strategies
employed by consumers in the event of needing
ª 2015 The Authors. Health Expectations Published by John Wiley & Sons Ltd.
Health Expectations
Community pharmacy privacy space, H L Hattingh et al.10
to approach pharmacy staff about a private mat-
ter. These included telephoning rather than
visiting the pharmacy and timing their visits to
off-peak periods to minimize witnesses to their
conversation. These approaches were also uti-
lized by pharmacists. Awareness of these
consumer strategies by pharmacy staff can guide
their service development. For example, if the
pharmacy cannot physically accommodate a pri-
vate counselling area, encouraging consumers to
telephone, and ensuring telephone conversations
are conducted in a quieter area of the pharmacy,
could go some way towards meeting their needs
for privacy.
Factors appearing to impact negatively on pri-
vacy in pharmacies included busy periods in the
pharmacy, busy areas of the pharmacy (e.g. main
medicines counter), and loud voices of staff,
sometimes necessitated by hearing-impaired con-
sumers. Pharmacists could advertise the less busy
periods as consultation times so consumers could
return during those periods for greater privacy.
Impact of practice changes on privacy
requirements
It is apparent some consumers did not have an
understanding of the changed role of pharmacists
or pharmacists’ need for personal information to
provide patient-centred care. Some consumers
did not perceive a need to provide sensitive infor-
mation to pharmacy staff or simply would not
share certain sensitive information with pharmacy
staff if requested. These consumers commented
that they would rather seek support or advice else-
where, for example from doctors or the Internet.
Indeed, inadequate privacy in pharmacies could
impact on consumers’ lack of appreciation for the
changed role of community pharmacists. Research
with mental health consumers similarly identified
a lack of knowledge and/or appreciation amongst
some consumers and carers about advanced phar-
macy services.32 A Welsh study investigating the
importance of professionalism in pharmacy prac-
tice showed clients often lack trust in speaking
with pharmacists if there is no privacy.33
Also evident in our data was differences
between consumers in their expectations of pri-
vacy. For some, common conditions such as
high blood pressure or high cholesterol required
less privacy while other consumers expected any
medical discussion to be conducted discreetly.
Of interest was that some older consumers felt
less need for discreet conversations compared to
younger consumers, although other characteris-
tics are also likely to be related to an individual’s
need for privacy.
Advanced services undertaken by pharma-
cists will bring to light new challenges relating
to the management of privacy. Barriers to the
disclosure of medical and personal informa-
tion could impact on pharmacists’ ability to
provide medication management services. This
is particularly important as the profession is
moving towards the provision of more profes-
sional services that involve talking to patients
about not only their medical history but also
lifestyle issues that could impact on their
health care.
Recent Australian research indicated that con-
sumers are often reluctant to engage with their
pharmacist and ask questions about their health
needs if they do not sense adequate privacy.34
Addressing perceptions about the role of com-
munity pharmacists is therefore especially
important with the profession providing more
disease state management services. American
research found that lack of privacy not only
impacts on consumers but could also impact on
pharmacists’ confidence to counsel consumers,
as community pharmacists were less confident in
counselling clients with obesity if they perceived
there was a lack of privacy.35
This study highlighted the need for pharmacy
staff to apply professional judgement in the use
of private areas and approaches to achieve pri-
vacy as well as the need to be sensitive to
consumers’ preferences. Several practice-related
challenges were identified for consideration by
pharmacy professional organizations. Specific
communication skills to enhance privacy, such
as lowering of voices, should be included in
undergraduate training. There is also a need for
on-going research in pharmacy privacy as the
profession moves towards increased provision of
professional services.
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Limitations
This study involved a sample of metropolitan
pharmacies. Due to logistical challenges, rural
pharmacies were not included. While most of the
consumers who participated in the interviews
were regular clients of the pharmacy in which
they were interviewed, privacy issues may
become even more amplified in smaller commu-
nities. It is also possible that familiarity with the
pharmacy and staff gave rise to positive reflec-
tions about the consumers’ comfort with
sensitive discussions and trust in the staff. Phar-
macists were involved in selection of consumers;
this was in accordance with ethical approval for
the study, such that the presence of a researcher
in the pharmacy randomly approaching con-
sumers would not create ill-feeling amongst the
clientele. To minimize pressure on consumers to
‘report on’ their pharmacy, consumers were
asked about their experiences and values relating
to privacy; some anecdotes relating to other
people were also shared. Our data may not
reflect other metropolitan centres in Australia,
where different cultural mixes of clientele exist.
In these cases, the importance of standards and
staff training around management of privacy
becomes even more paramount.
Conclusion
Due acknowledgement and management of pri-
vacy can be challenging in the community
pharmacy environment. On-going work in this
area is therefore important. As community phar-
macy practice is increasingly involved in
advanced medication management and disease
state management services with unique privacy
requirements, pharmacy layouts and systems to
address privacy challenges must evolve. This
requires a proactive approach in pharmacy
design and the development of guidelines to
rectify identified gaps in compliance. The infor-
mation from this study provides valuable insight
into community pharmacy experiences and
expectations that should inform the profession
in the development of privacy strategies.
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